Biomerica has received its first commercial order for Hp Detect(TM), from one of the largest clinical laboratory chains operating across Europe. -- Strategic Account: This new lab's scale and ...

Emphysematous gastritis is a rare and life-threatening condition often caused by gas-forming bacterial infections. This case describes a woman in her 40s with no significant medical history, ...

Biomerica has received its first commercial order for Hp Detect™, from one of the largest clinical laboratory chains operating across Europe. Strategic Account: This new lab’s scale and geographic ...

In the United States, the Shield MCD test has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) based on its strong performance in predicting the presence of ...

The Shield MCD test will be available to eligible Manulife customers beginning April 2026.

MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active ...

Scientists at the Queensland University of Technology (QUT) in Australia have developed a new saliva test that could help ...

MHRA registration authorizes hp+detect(TM) for commercial sale in Great Britain -- Active Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic laboratory ...

QUT researchers have developed a simple one-hour saliva test for a protein biomarker that has been linked with oral, colon ...

Gastric cancer (stomach cancer) develops when cells lining the inner surface of the stomach become cancerous and begin to grow uncontrollably. In Japan, it remains one of the most common types of ...

Introduction Dysphagia accounts for a large proportion of 2ww referrals for direct-to-test gastroscopy, but patients often receive no medical input or explanation for their symptoms. Additionally, ...